Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the School Safety topic
No spam. Unsubscribe anytime.
Board discusses Narcan availability and safety procedures; refers matter to safety committee
Summary
Board members raised questions about keeping Narcan in school buildings and training for staff; superintendent said Narcan availability is currently tied to SROs and clinics and recommended bringing the issue to the safety committee for further research and law‑enforcement input.
During board comments at the July 14 meeting, a board member asked whether Narcan (naloxone) is available in district buildings. Superintendent Dr. Brian Goggin responded that Narcan is currently carried by school resource officers and that district staff had discussed over‑the‑counter Narcan for clinic use. He said the district previously adopted board policy that allows use of life‑saving medications where appropriate.
Board members raised practical concerns about layperson administration and training, comparing Narcan to EpiPen use: even when staff have training, they may feel hesitant to act in a high‑stress situation. Dr. Goggin suggested that the topic would be appropriate for the district safety committee and that the committee should consult local law enforcement and emergency responders. He noted the committee could review distribution (clinics, SROs, staff locations), training needs, and related policy implications.
No formal board action was taken; members asked staff to research options and discuss the matter at upcoming safety‑committee meetings. The superintendent said Narcan can be obtained through state channels and that the district could evaluate protocols and training before any districtwide deployment.
